RE:RE:Spectral Medical content from Baxter Invester Day 2022Accountprince wrote: Thanks Tom - the presentation certainly highlights the PMX and EAA products. I don't think Baxter would put them in as definitively as they show here if they weren't virtually certain of success. Heather as well would want to maintain her credibility so would be reluctant to commit to anything that could come back to haunt her. This is HUGE as it does validate some of the things Spectral management has been saying. But Baxter has the credibility Spectral management lacks right now. Anyone that is still skeptical of success should spend some time to evaluate their position.
MM - thanks for your musings - always appreciated. My only comment is that Baxter is not a "tire kicker" but truly a partner based on the Investor presentation they did independantly. It would be wonderful to be an insider and know the deal with Baxter unredacted. At least now we know Spectral is cleared in Baxter's plans. Very encouraging.
Great find...and kudos to Tom !
I agree with all of your conclusions above Ap. Huge validation.
"tire kicking" in the medical diagnostic and device fields can take many forms including:
- years and years of negotiations (often as Trials progress)
- the provision of $ xxxxxx millions by the ultimate distributor/liscensee to the developer/Trial conductor, in order to secure first rights,
- casual to advanced discussions with other possible acquirors, distributors, partners.
- support efforts & assistance to the FDA effort (e.g. assistance in getting the Trial across the goal line). Credible partners in the wings, also huge.
- etc.
I note that there is no direct evidence in the presentation that Baxter would like to acquire the second trick pony (at least not yet, and at least not in the same way that PMX, and the EAA is called out) Nevertheless I think that many companies are looking for a ways to tackle/enter/exploit what looks to be, in the near future, a major part of the new paradigm in the dialysis market (namely HD and PD). There has to be (should be) many tire kickers given the limited number of players so far (and still many barriers to adoption that the currently FDA approved devices have thusfar failed to overcome)
Also, back to PMX, I wonder if Baxter could be convinced to cough up $
xxxxxxx million a little bit early, as a good current & futue "partner" might (given the unusual circumstances of inordinate Trial delays in the midst of a once in a 100 years pandemic)
MM